To the full analysis
VEON stock: growth
VEONVEON reported $4.47B in revenue for fiscal 2025, up 11.8% on the prior year, up 5.1% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−0.4%
per year from 2006 to 2025, per share −3.4%
Earnings (Annual rate)
−2.1%
per year from 2006 to 2025, per share −5%
Free cash flow (Annual rate)
2.1%
per year from 2006 to 2025, per share −0.9%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 5.1% | −7.4% | −0.4% |
| Revenue per share | 4.6% | −7.6% | −3.4% |
| Earnings | no data | no data | −2.1% |
| Earnings per share | no data | no data | −5.0% |
| Free cash flow | −18.6% | no data | 2.1% |
| Free cash flow per share | −19.0% | no data | −0.9% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $4.87B | $811.49M | $424.58M |
| 2007 | $7.17B | $1.46B | $1.43B |
| 2008 | $10.12B | $524.33M | $1.44B |
| 2009 | $8.7B | $1.12B | $2.82B |
| 2010 | $10.51B | $1.81B | $1.89B |
| 2011 | $20.25B | $543M | −$154M |
| 2012 | $23.06B | $1.54B | $3.37B |
| 2013 | $15.97B | −$1.99B | $2.4B |
| 2014 | $13.49B | −$647M | $790M |
| 2015 | $9.61B | −$655M | −$173.32M |
| 2016 | $8.89B | $2.33B | $227.36M |
| 2017 | $9.47B | −$505M | $439.43M |
| 2018 | $9.09B | $582M | $568.5M |
| 2019 | $8.05B | $622.01M | $1.37B |
| 2020 | $3.48B | −$349M | $1.76B |
| 2021 | $3.85B | $674M | $1.94B |
| 2022 | $3.76B | −$162M | $1.92B |
| 2023 | $3.7B | −$2.53B | $1.58B |
| 2024 | $4B | $415M | $523M |
| 2025 | $4.47B | $541.13M | $630.64M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 7 Aug 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.